Literature DB >> 1248674

Metabolism of forearm tissues in man. Studies with glucagon.

T Pozefsky, R G Tancredi, R T Moxley, J Dupre, J D Tobin.   

Abstract

The role of glucagon in regulating peripheral tissue metabolism in man was assessed in the present studies. To do this, glucagon was infused for two hours into the brachial artery to produce a high but physiologic increment in the glucagon content of arterial blood supplying ipsilateral tissues. Metabolic effects on muscle and on subcutaneous adipose tissue plus skin were sought in seven overnight-fasting subjects and seven subjects starved briefly (60 hours). In the overnight-fasted group the infusion increased bassl glucagon concentration by 1,216 pg./ml. but was without effect on forearm tissue metabolism of glucose, lactate,glycerol, or amino acids. Starvation significantly reduced basal insulin (11.0 to 7.4 muU./ml.) and increased endogenous glucagon (116 to 134 pg./ml.). Basally, there was substantial ketone utilization and a decrease in glucose consumption by both muscle and subcutaneous adipose tissue plus skin. The glucagon infusion increased basal glucagon by 784 pg./ml. Muscle balances of glucose, lactate, acetoacetate, amino acids, and glycerol were unaffected. The metabolism of glucose, lactate, acetoacetate, glycerol, and free fatty acids by subcutaneous adipose tissue plus skin was also unchanged. It is concluded that physiologic increments of glucagon lasting two hours are without effect on forearm tissues in overnight-fasted and briefly starved man.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1248674     DOI: 10.2337/diab.25.2.128

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

1.  Metabolic effects of glucagon in endogenous hypertriglyceridemia.

Authors:  R Nosadini; G Soldà; F de Biasi; A Tiengo
Journal:  Acta Diabetol Lat       Date:  1978 Sep-Dec

2.  Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy.

Authors:  S Del Prato; S Vigili de Kreutzenberg; R Trevisan; E Duner; A Avogaro; R Nosadini; U Baccaglini; C Tremolada; A Tiengo
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

3.  Effects of glucagon on plasma amino acids.

Authors:  G Boden; I Rezvani; O E Owen
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

4.  Possible mechanism by which somatostatin-induced glucagon suppression improves glucose tolerance during insulinopaenia in man.

Authors:  J E Liljenquist; Z T Bloomgarden; A D Cherrington; J M Perry; D Rabin
Journal:  Diabetologia       Date:  1979-09       Impact factor: 10.122

5.  Role of counterregulatory hormones in the catabolic response to stress.

Authors:  R A Gelfand; D E Matthews; D M Bier; R S Sherwin
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

6.  Roles of glucagon and insulin in the regulation of metabolism in ruminants. A review.

Authors:  R P Brockman
Journal:  Can Vet J       Date:  1978-03       Impact factor: 1.008

7.  Does glucagon play a role in the insulin resistance of patients with adult non-ketotic diabetes?

Authors:  J M Olefsky; M A Sperling; G M Reaven
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

8.  The effect of glucagon administration on protein synthesis in skeletal muscles, heart and liver in vivo.

Authors:  V R Preedy; P J Garlick
Journal:  Biochem J       Date:  1985-06-15       Impact factor: 3.857

9.  Hyperglucagonemia and insulin-mediated glucose metabolism.

Authors:  S Del Prato; P Castellino; D C Simonson; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

10.  Idiopathic reactive hypoglycemia: a role for glucagon?

Authors:  F Leonetti; L Morviducci; A Giaccari; P Sbraccia; S Caiola; D Zorretta; O Lostia; G Tamburrano
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.